Sentences with word «evaluable»

For 124 evaluable patients for concordance analysis, researchers compared genetic changes in the tumors to those in circulating tumor DNA from the blood samples.

For the first time in the assessment of a hepatitis C drug, the manufacturer dossier contained evaluable data on health - related quality of life, which is of particular importance regarding interferon, which is considered to be very burdensome.

Of 22 patients evaluable for response, 3 (14 percent) had very good partial responses, 3 (14 percent) had minor responses, and 10 (45 percent) had a period of stable disease.

Four patients had stable disease, nine patients had progressive disease, and three were not evaluable for response.

In addition, 50 % of evaluable patients experienced shrinkage of untreated distal (abscopal) lesion.

A follow - up of the 48 patients who were evaluable at a median time of 24 months indicated no statistical differences between the two groups in terms of overall or progression - free survival.

Implementing a scalable, evaluable pilot project in a smaller centre would, I think, use fewer resources, be easier to organize and adapt, and facilitate public engagement.

For such projects, he suggested that effective ways to evaluable progress can include:

For patients with cirrhosis of the liver, sufficient and evaluable data are still not available.

Responses were observed in untreated lesions in 59.1 % of evaluable patients (13/22).

In a recent randomized trial, dogs treated with vinblastine alone had the following tumor responses: 22 % partial remission, 70 % stable disease, and 4 % progressive disease, and 4 % were not evaluable for tumor response.

Such an added benefit can not be derived from the dossier because it contained no data evaluable for the assessment.

Finally, you'll need to analyze how competitive each keyword phrase is — in other words, evaluable the relative difficulty of ranking for each niche keyword.

Pea protein not only offers all of these evaluable amino acids, but it contains another class that has gained a lot of attention over the past few years: branched chain amino acids (BCAAs).

Among patients who were resistant to enzalutamide, nine were evaluable; five out of nine (56 %) had any PSA decline.

According to the authors, women have thus far been clearly underrepresented in available studies, and no evaluable data were available to date on classical «women's jobs» that entail physical strain (e.g. nursing).

Of the 24 evaluable patients (those whose response to a treatment could be measured because enough information was collected) who were enrolled in the study:

Eight of nine patients who are evaluable for response had no evidence of disease in their bone marrow at three months, and all remain in remission after a median follow - up period of six months, with a range from 0.5 to 9 months.

Among the evaluable patients in the newly reported phase II study, 23 (58 %) achieved complete response to the combination within four cycles, and 6 (15 %) had a partial response.

The dossier contained no evaluable data on quality of life.

The objective response rate (defined as the proportion of complete response and partial responses among all evaluable patients) was also higher with chemotherapy (92/549, 16.8 percent) compared with TKI (39/540, 7.2 percent).

There were no evaluable data for the docetaxel population.

However, there were no evaluable data for this comparison.

The data on health - related quality of life presented by the manufacturer were either not evaluable (EQ - 5D) or subject to great uncertainty (FACT - P).

For the same reason, the data on symptoms that were also recorded with EORTC QLQ - C30 are also not evaluable.

No evaluable data were available for the comparison with docetaxel in patients in whom prolongation of life was the primary treatment goal.

Among an additional 11 evaluable patients who did not have the T790M mutation, four had a confirmed response to the treatment (overall response rate of 36 %) and this group of patients had a median progression - free survival of 7.5 months.

The 11 evaluable patients enrolled in the brain cancer safety trial received three infusions of vitamin C a week for 2 months followed by two infusions per week for 7 months while receiving standard care radiation and chemotherapy.

Among 30 patients who were evaluable for response, 4 of 13 responded at the lower dose (one complete remission and three partial responses, ORR = 31 percent) and nine of 17 responded at the higher dose (six complete remissions and three partial responses, ORR = 53 percent).

All 35 patients were evaluable for toxicity, with 19 experiencing varying degrees of CRS, four of who were treated with tocilizumab.

A total of 59 patients were accrued for the study, and 55 were evaluable (44 patients with T1 tumors and 11 patients with T2 tumors).

The early numbers at AACR: 15 of 69 evaluable patients (22 percent) who had failed a median of two treatments, including checkpoint therapy, responded to the CMP -001-pembrolizumab combination.

Of the 61 patients (median age 68 years), 38 received AZA and 23 received LDAC; 59 patients were evaluable for response.

Researchers at Children's National Health System are reporting in a study published online ahead of print in the Journal of Clinical Oncology that four of seven evaluable patients with active disease achieved clinical responses with tumor - specific T cells that were genetically modified to be rendered resistant to transforming growth factor beta (TGF - β).

Of the 30 evaluable patients, 1 patient achieved a complete response, 1 had a partial response, and 6 patients had stable disease by immune - related response criteria.

In early results, of 16 evaluable patients, 9 had objective responses (56.3 %); the disease control rate was 68.8 %.

Altogether, 54 cases and 45 controls were evaluable for FMc.

Of the 16 evaluable patients, 9 achieved an objective response (56.3 %) and the disease control rate was 68.8 %.